Risperidone monotherapy pediatric bipolar disorder - [BINGH2]

References To the Editor: Recently, risperidone alone or, mostly, in combination with other mood stabilizers has been tried in the treatment of pediatric disorder 12. Nevertheless, its effects on mood seem bipolar predictable: We describe a patient disorder bipolar disorder in monotherapy risperidone monotherapy exhibited marked efficacy for his sequential manic and depressive states.

A, a year-old man of Chinese descent, was physically healthy and did not abuse substances. Elevated moods, lessened need for sleep, hyperactivity, risperidone monotherapy pediatric bipolar disorder, pressured speech, flight of ideas, grandiosity, and visual, mood-congruent hallucinations significantly impaired various areas of functioning.

In addition, his elder brother was also a victim of bipolar disorder.

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia.

monotherapy A and his father gave pediatric informed consent bipolar him to receive risperidone monotherapy; his risperidone was titrated to 3 mg b. Both psychotic and mood symptoms vanished within 3 weeks; he was then transferred to our outpatient department with the same drug regimen.

Two weeks later, Mr.

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

A abruptly discontinued his medication because of a lack of full insight; after 6 days, a less severe manic state without psychotic features returned. Five days later, risperidone alone 3 mg b.

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.

Unfortunately, 1 month later, he again discontinued his medication; a DSM-IV major depressive episode with melancholic features ensued 1 week later. Distinct depressed moods, significant anorexia, early morning awakening, loss of energy, marked psychomotor retardation, loss of pleasure in all activities, excessive guilt, and feelings of hopelessness caused drastic distress.

After another 2 weeks, the risperidone monotherapy alleviated the disorder bipolar within 1 week. Three weeks later, Mr. A halted the medicine for a pediatric time.

Thereafter, he was free of psychotic and mood symptoms for 9 months, until another major depressive episode with similar symptoms developed. Two weeks later, the earlier treatment strategy curtailed this episode over 1 week, risperidone monotherapy pediatric bipolar disorder.

No adverse drug reaction ever emerged; no other medication, monotherapy as an adjunct, was coadministered throughout. To our knowledge, this is the first report of risperidone monotherapy for both manic and depressive episodes of bipolar disorder.

Rigorous studies are needed to examine this preliminary observation. Am J Psychiatry ; Mania induced by risperidone: J Clin Psychiatry ; Access to courses requires a psychiatry.

Risperidone’s 2 new pediatric indications

With your personal account at education. Personalized CME recommendations based on your interests. All article courses developed during the current year.

All courses from the previous year. All courses for the following year.